Skip to main content Skip to navigation


Select tags to filter on

NanoSyrinx raises £6.2m to develop its synthetic biology platform for targeted intracellular engineering

Coventry, United Kingdom, 19th July 2021 – NanoSyrinx, a biotech company developing a new cell engineering tool for novel targeted therapeutic modalities, has raised a further £6.2m of seed financing, co-led by incoming Octopus Ventures and existing investor M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck KGaA. Previous investors BioCity and the UK Innovation & Science Seed Fund (UKI2S) joined the funding round along with experienced deeptech investor IQ Capital and Jonathan Milner. The round was significantly oversubscribed with high demand both from existing and from new investors.

Dr James Lapworth, Warwick Innovations, who has worked closely with the founding team since 2016 to develop the commercialisation strategy for the technology, said: “This latest investment into NanoSyrinx is a huge vote of confidence in the technology and in the team. It recognises not only the potential impact that nanosyringes could have as advanced medicines but also the entrepreneurial talent emerging from our researcher community.”

Nanosyrinx Funding Press Release

For commercial enquiries contact Dr James Lapworth, Warwick Innovations, email:

Universities of Birmingham and Warwick form spinout company, 4D Medicine Ltd, to take new family of biomedical 3D printing resins to market

The Universities of Birmingham and Warwick have created a new spinout company, 4D Medicine Ltd, to commercialise a new class of materials – liquid resins that can be printed into solid 3D scaffolds to help patients recover from major medical procedures more quickly.

Mon 20 Jul 2020, 14:25 | Tags: Life Sciences and Biotechnology, investors

Verdel Instruments secures £1 million equity funding from Longwall Ventures

Verdel is a UK-based company pushing the boundaries of complex sample analysis using innovative Two-Dimensional Mass Spectrometry (2DMS) technology

Tue 07 Apr 2020, 09:44 | Tags: Warwick Ventures, investors